Discromic neurocutaneous syndroms;Sindromes neurocutaneos discromicos

Revista de Neurologia

Volumn 25, Issue SUPPL. 3, 1997, Pages

  Sola Casas, M A ^a   Salleras Redonnet, M ^a  

^a HOSPITAL UNIVERSITARI SAGRAT COR   (Spain)

Author keywords

Discromies; Neurocutaneous syndroms; Skin

Indexed keywords

ATAXIA TELANGIECTASIA; CHEDIAK HIGASHI SYNDROME; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; HUMAN; INCONTINENTIA PIGMENTI; LENTIGINOSIS; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; PHAKOMATOSIS; PIEBALDISM; REVIEW; SKIN DISEASE; TUBEROUS SCLEROSIS; WAARDENBURG SYNDROME; FEMALE; GENETICS; HEMANGIOFIBROMA; MALE; PATHOLOGY; PIGMENT DISORDER; SKIN TUMOR; SYNDROME;

ANGIOFIBROMA; FEMALE; HUMANS; MALE; NEUROFIBROMATOSES; PIGMENTATION DISORDERS; SKIN NEOPLASMS; SYNDROME; TUBEROUS SCLEROSIS;

EID: 0030710481     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (8)

1. Riccardi VM. Neurofibromatosis. Von Recklinghausen neurofibromatosis. N Engl J Med 1981; 305: 1617-28.
2. Riccardi VM, Eichner JE. Neurofibromatosis phenotype. Natural history and pathogenesis. Baltimore: John Hopkins University Press; 1986.
3. Riccardi VM. Molecular biology of the neurofibromatoses. Sem Dermatol 1993; 12:266-73.
4. Pascual Castroviejo I. Neurofibromatosis tipo 1 (NFl):peculiaridadesy complicaciones. RevNeurol 1996; 24: 1051-5.
5. Shannon KM, O'Connell P, Martin GA, et al. Loss of the normal NF1 allelle from the bone marrow of children with neurofibromatosis and malignant myeloid disorders. N England J Med 1994; 330: 597-601.
6. Chan Le, Kwong YL,Ha SY. Neurofibromatosis and increased risk for leukemia. Is the GCSF gene involved? Leukemia 1991; 5: 1113-4.
7. Zvulunov A, Barak Y, Metzner A. Juvenil xantogranuloma, neurofibromatosis andjuvenil chronic mielogenous leukemia. Arch Dermatol 1995; 131:904-8.
8. Schnur RE. Tuberous Sclerosis. The persistent challenge of clinical diagnosis. Arch Dermatol 1995; 131: 1460-2.